ask="0.770"
ask_size="11800"
average_daily_volume="165528"
bid="0.730"
bid_size="700"
book_value="0.725"
change="+0.099"
change_from_200_day_moving_average="-0.570"
change_from_50_day_moving_average="-0.209"
change_from_52_week_high="-1.281"
change_From_52_week_low="0.159"
change_in_percent="+15.986%"
close="0.719"
dividend_pay_date="11/8/2012"
dividend_per_share="0.000"
dividend_yield="0.000"
earnings_per_share="-0.810"
ebitda="-30.60M"
eps_estimate_current_year="-0.930"
eps_estimate_next_quarter="-0.230"
eps_estimate_next_year="-0.860"
ex_dividend_date="11/9/2012"
float_shares="30530000"
high="0.760"
high_52_weeks="2.000"
last_trade_date="3/10/2017"
last_trade_price="0.719"
last_trade_size="2598"
last_trade_time="4:00pm"
low="0.585"
low_52_weeks="0.560"
market_capitalization="27.79M"
moving_average_200_day="1.289"
moving_average_50_day="0.928"
name="Aviragen Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.170"
open="0.640"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-44.213%"
percent_change_from_50_day_moving_average="-22.522%"
percent_change_from_52_week_high="-64.050%"
percent_change_from_52_week_low="+28.393%"
previous_close="0.620"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.855"
price_per_sales="2.445"
revenue="9.80M"
shares_outstanding="38649000"
short_ratio="0.380"
stock_exchange="NMS"
symbol="AVIR"
volume="865046"
weeks_range_52="0.560 - 2.000"
